Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Cara Therapeutics Inc. buy geldnutzer

Start price
€15.39
03.07.17 / 50%
Target price
€20.30
20.10.17
Performance (%)
-28.72%
End price
€10.97
20.10.17
Summary
This prediction ended on 20.10.17 with a price of €10.97. The prediction for Cara Therapeutics Inc. disappointed with a performance of -28.72%. geldnutzer has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Cara Therapeutics Inc. -18.432% -18.432% -81.805% -94.811%
iShares Core DAX® -0.683% 1.890% 15.367% 17.155%
iShares Nasdaq 100 0.335% 4.631% 29.818% 56.187%
iShares Nikkei 225® -1.486% -2.361% 7.668% 3.633%
iShares S&P 500 -0.523% 2.324% 25.460% 46.452%

Comments by geldnutzer for this prediction

In the thread Cara Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -28.72%
Target price 20.295
Change
Ends at 20.10.17

geldnutzer stimmt dem Sentiment von 'Sell' nicht zu

geldnutzer stimmt am 03.07.2017 dem Sell-Gesamtsentiment mit dem Kursziel 11.0$ nicht zu.

Prediction Buy
Perf. (%) -28.72%
Target price 20.295
Change
Ends at 20.10.17

(Vom Mitglied beendet)